Literature DB >> 8625089

Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma.

A H Hölscher1, E Bollschweiler, P M Schneider, J R Siewert.   

Abstract

BACKGROUND: The purpose of this study was to compare the prognosis of patients with T1 squamous cell carcinoma (SCC) with those with T1 adenocarcinoma of the esophagus and to explain prognostic differences by an analysis of clinicopathologic characteristics.
METHODS: Seventy-seven patients with early esophageal cancer who underwent esophagectomy and lymphadenectomy from 1982 to 1993 were included in the study. Clinical and histopathologic characteristics, patterns of lymph node metastasis, results of surgery, and long term prognosis of 47 patients with SCC were compared with 30 patients with adenocarcinoma; a multivariate analysis of various prognostic factors was performed.
RESULTS: The groups with adenocarcinoma and SCC were comparable regarding age, postoperative 90-day mortality (6.6% vs. 8.5%), infiltration of submucosa (74.5% vs. 80%), and rate of lymph node metastasis (17% vs. 16.6%). Cancer limited to the mucosa was not associated with lymph node metastasis in either group, whereas submucosal spread showed lymph node involvement in 21% of patients with adenocarcinoma and 26% of those with SCC. The 5-year survival rate of patients with complete tumor removal was superior for those with adenocarcinoma (82.5%) compared with those with SCC (59.2%) (P < 0.03). Multivariate analysis indicated that the histopathologic type (adenocarcinoma vs. SCC) was the only independent prognostic factor. The unfavorable prognosis of patients with T1 SCC was due to a higher recurrence rate and the more frequent development of second primary tumors (21% vs. 0%).
CONCLUSIONS: The prognosis of patients with early esophageal cancer depends on the histologic tumor type. Patients with T1 SCC should be examined for another primary cancer before surgery and during follow-up.

Entities:  

Mesh:

Year:  1995        PMID: 8625089     DOI: 10.1002/1097-0142(19950715)76:2<178::aid-cncr2820760204>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  38 in total

1.  Can extent of high grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy?

Authors:  M S Dar; J R Goldblum; T W Rice; G W Falk
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

2.  Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia.

Authors:  Chin Hur; Norman S Nishioka; G Scott Gazelle
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

Review 3.  Neoadjuvant treatment of esophageal cancer.

Authors:  Nicholas P Campbell; Victoria M Villaflor
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

4.  [Preoperative evaluation of prognostic factors in esophageal squamous cell cancer].

Authors:  P M Schneider; D Vallböhmer; J Brabender; A H Hölscher
Journal:  Chirurg       Date:  2005-11       Impact factor: 0.955

Review 5.  Surgical treatment of superficial esophageal cancer.

Authors:  Mitsuo Tachibana; Shoichi Kinugasa; Muneaki Shibakita; Yasuhito Tonomoto; Shinji Hattori; Ryoji Hyakudomi; Hiroshi Yoshimura; Dipok Kumar Dhar; Naofumi Nagasue
Journal:  Langenbecks Arch Surg       Date:  2006-07-08       Impact factor: 3.445

6.  Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma.

Authors:  Christophe Mariette; Laetitia Finzi; Guillaume Piessen; Isabelle Van Seuningen; Jean Pierre Triboulet
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

7.  Limited resection for early esophageal cancer?

Authors:  W Schröder; C A Gutschow; A H Hölscher
Journal:  Langenbecks Arch Surg       Date:  2003-04-01       Impact factor: 3.445

8.  Mortality after esophagectomy is heavily impacted by center volume: retrospective analysis of the Nationwide Inpatient Sample.

Authors:  Hans F Fuchs; Cristina R Harnsberger; Ryan C Broderick; David C Chang; Bryan J Sandler; Garth R Jacobsen; Michael Bouvet; Santiago Horgan
Journal:  Surg Endosc       Date:  2016-09-22       Impact factor: 4.584

9.  Transthoracic esophagectomy after endoscopic mucosal resection in patients with early esophageal carcinoma.

Authors:  W Schröder; K Wirths; C Gutschow; D Vallböhmer; M Bludau; B Schumacher; H Neuhaus; A H Hölscher
Journal:  J Gastrointest Surg       Date:  2008-10-16       Impact factor: 3.452

10.  Comparison of oncological outcomes after laparoscopic transhiatal and open esophagectomy for T1 esophageal adenocarcinoma.

Authors:  Arin Kumar Saha; Christopher D Sutton; Henry Sue-Ling; Simon P L Dexter; Abeezar I Sarela
Journal:  Surg Endosc       Date:  2008-07-15       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.